Provided by Tiger Fintech (Singapore) Pte. Ltd.

CRISPR Therapeutics AG

63.01
+0.07000.11%
Volume:1.99M
Turnover:126.04M
Market Cap:5.73B
PE:-11.57
High:64.18
Open:63.18
Low:62.46
Close:62.94
52wk High:71.13
52wk Low:30.04
Shares:90.95M
Float Shares:90.53M
Volume Ratio:1.33
T/O Rate:2.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.4437
EPS(LYR):-4.3416
ROE:-25.34%
ROA:-13.05%
PB:3.35
PE(LYR):-14.51

Loading ...

Sep 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Aug 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jul 29, 2021

Major Issues Report

8-K - Current report
Jul 29, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 14, 2021

Major Issues Report

8-K - Current report
Jun 11, 2021

Major Issues Report

8-K - Current report
Jun 02, 2021

Major Issues Report

8-K - Current report
Apr 27, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 27, 2021

Major Issues Report

8-K - Current report
Apr 20, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 16, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 05, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 15, 2021

Major Issues Report

8-K - Current report
Dec 17, 2020

Major Issues Report

8-K - Current report
Dec 11, 2020

Major Issues Report

8-K - Current report